Intravenous Ceftriaxone Pediatric Dosing
For most pediatric infections beyond the neonatal period, administer ceftriaxone 50–75 mg/kg/day IV once daily or divided every 12 hours (maximum 2 g/day for non-meningeal infections), and for bacterial meningitis use 100 mg/kg/day IV once daily or divided every 12 hours (maximum 4 g/day). 1, 2
Neonatal Dosing (Age-Specific)
Critical contraindication: Never use ceftriaxone in hyperbilirubinemic neonates due to risk of bilirubin encephalopathy. 1, 2
- Postnatal age ≤7 days: 50 mg/kg/day IV every 24 hours 1
- Postnatal age >7 days and weight ≤2000 g: 50 mg/kg/day IV every 24 hours 1
- Postnatal age >7 days and weight >2000 g: 50–75 mg/kg/day IV every 24 hours 1
- Infusion time for neonates: Administer over 60 minutes (not 30 minutes) to reduce risk of bilirubin encephalopathy 2
Infants and Children Beyond Neonatal Period
Standard Dosing by Infection Severity
Moderate infections (skin/soft tissue, uncomplicated pneumonia, UTI):
Severe infections (sepsis, complicated pneumonia, intra-abdominal infections):
Bacterial meningitis:
- Initial loading dose: 100 mg/kg IV (maximum 4 g) 2
- Maintenance: 100 mg/kg/day IV once daily or divided every 12 hours (maximum 4 g/day) 1, 2
- Duration: 7–14 days typically 2
- Once-daily dosing is superior for meningitis: Recent pharmacokinetic modeling demonstrates 100 mg/kg once daily achieves 88% probability of target attainment at 24 hours versus only 53% for 50 mg/kg twice daily, with earlier achievement of therapeutic CSF concentrations 4
Indication-Specific Dosing
Community-acquired pneumonia:
- Standard: 50–100 mg/kg/day IV once daily or divided every 12 hours 1
- Penicillin-resistant Streptococcus pneumoniae: Use 100 mg/kg/day divided every 12–24 hours 1
Gonococcal infections (weight <45 kg):
- Uncomplicated: 125 mg IM single dose 1
- Bacteremia/arthritis: 50 mg/kg/day IV/IM once daily for 7 days (maximum 1 g) 1
- Meningitis: 50 mg/kg/day IV/IM once daily for 10–14 days (maximum 2 g) 1
Gonococcal conjunctivitis:
- 25–50 mg/kg IV or IM single dose (maximum 250 mg) 1
Infective endocarditis (HACEK organisms):
- 100 mg/kg/day IV/IM once daily for 4 weeks (native valve) or 6 weeks (prosthetic valve)
- Maximum 4 g/day 1
Streptococcal endocarditis:
- 100 mg/kg/day divided every 12 hours OR 80 mg/kg/day every 24 hours (maximum 4 g/day) 1
Administration Guidelines
Intravenous infusion:
- Standard: Infuse over 30 minutes 2
- Neonates: Infuse over 60 minutes 2
- Concentration: 10–40 mg/mL recommended 2
Intramuscular injection:
- Inject deep into large muscle mass 1
- Counsel families that IM injection is painful 1
- Concentration: 250 mg/mL or 350 mg/mL 2
Renal and Hepatic Impairment
No dose adjustment required for renal or hepatic impairment in pediatric patients, provided there is no severe combined renal and hepatic dysfunction. 2
Critical Dosing Considerations
Do not underdose severe infections:
- Always use 80–100 mg/kg/day for life-threatening infections, empyema, or documented resistant pathogens 3
- For critically ill children with estimated GFR >80 mL/min/1.73 m² or areas with high prevalence of less-susceptible pathogens (MIC ≥0.5 mg/L), consider 50 mg/kg twice daily instead of 100 mg/kg once daily to improve target attainment 5
Weight threshold for adult dosing:
- Children weighing ≥45 kg should receive adult dosing regimens 1
Maximum daily doses:
Common Pitfalls to Avoid
- Never use in hyperbilirubinemic neonates — risk of kernicterus 1, 2
- Do not use calcium-containing diluents (Ringer's, Hartmann's) — particulate formation occurs 2
- Do not mix with vancomycin, aminoglycosides, amsacrine, or fluconazole — incompatible in admixtures; flush lines thoroughly between administrations 2
- Do not use lower dosing range (50 mg/kg/day) for severe sepsis — inadequate for critically ill patients 1
- For suspected staphylococcal infection, add flucloxacillin 50 mg/kg every 6 hours plus gentamicin 7.5 mg/kg daily — ceftriaxone alone insufficient for S. aureus meningitis 1, 4
- For suspected Listeria, add ampicillin 50 mg/kg every 6 hours — ceftriaxone has no activity against Listeria 1